Daily versus alternate day oral iron for iron deficiency anemia

A Pilot Randomized control trial of daily versus alternate day oral iron for the treatment of iron deficiency anemia

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/07/015106

Enrollment

100

Registered

2018-07-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Iron deficiency anemia

Interventions

Intervention1: Tab. Ferrous sulfate 400mg PO empty stomach on alternate days: Two tablets of Ferrous sulfate 200mg taken together on alternate days Control Intervention1: Tab. Ferrous sulfate 200mg PO

Eligibility

Inclusion criteria

Inclusion criteria: 1. Iron deficiency anemia diagnosed as serum ferritin 2. Patients of IDA with moderate anemia (8-10.9 g/dl) and severe anemia (6-8 g/dl)

Exclusion criteria

Exclusion criteria: 1. Patients or parents of patients 15-18 years not willing to give informed consent 2. Patients with Hb 3. Patients of severe anemia in cardiac failure 4. Patients having mild IDA (Hb>=11g/dl) 5. Pregnant females with IDA. 6. Patient with ongoing iron malabsorption or bleed 7. Patient with IDA having mixed etiology for anemia (megaloblastic/ anemia of chronic disease)

Design outcomes

Primary

Measure	Time frame
2g/dl hemoglobin riseTimepoint: 3 weeks (day 22)	—

Secondary

Measure	Time frame
Normalization of hemoglobinTimepoint: 6 weeks	—

Countries

India

Contacts

Public ContactDr Rahul Kaundal

Post Graduate Institute of Medical Education and Research

deepesh.kem@gmail.com9417770112

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 1, 2026